Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company best known for the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The ALGN news feed on Stock Titan aggregates company announcements, clinical product updates, financial disclosures, and professional education highlights directly relevant to investors and dental professionals.
Recent news shows Align focusing on digital orthodontics and restorative dentistry, with updates on innovations such as ClinCheck® Live Plan for automated Invisalign treatment planning, new features for iTero Digital Solutions, and expanded availability of Invisalign System options like mandibular advancement with occlusal blocks for Class II correction in growing patients. News items also cover Align’s participation in major dental congresses, including the Greater New York Dental Meeting, where the company showcases its Align™ Digital Platform and related tools.
Investors following ALGN news will see regular earnings announcements and outlook updates, including quarterly revenue, clear aligner volumes, imaging systems and CAD/CAM services performance, and commentary on geographic trends. SEC-related press releases, such as those tied to Form 8-K filings on financial results or leadership changes, also appear in the news flow.
Align’s communications further highlight research, education, and community programs, including its Annual Research Award Program for university-based dental research and partnerships with organizations like the Canadian Foundation for the Advancement of Orthodontics through Smiles4Canada. For users tracking ALGN, this news page offers a centralized view of product launches, clinical innovations, financial milestones, and corporate initiatives that shape the company’s role in digital dentistry.
Align Technology (Nasdaq: ALGN) announced that President and CEO Joe Hogan has personally purchased approximately $1 million of Align's common stock. This purchase adds to his previous investments, totaling approximately $8 million in stock purchases since his last sale in 2021.
Hogan emphasized his confidence in Align's long-term value and commitment to increasing shareholder value through strategic investments in growth and next-generation technologies. Despite acknowledging ongoing macroeconomic uncertainties, the company maintains its focus on transforming treatment through its Invisalign® System, iTero™ scanners, and exocad™ software, serving over 286,400 doctor customers and targeting a 600 million consumer market opportunity worldwide.
Align Technology (NASDAQ:ALGN) reported mixed Q2 2025 financial results with total revenues of $1,012.4 million, up 3.4% sequentially but down 1.6% year-over-year. Clear Aligner revenues were $804.6 million, declining 3.3% year-over-year, while Imaging Systems revenues grew 5.6% to $207.8 million.
The company reported Q2 GAAP operating income of $163.0 million with a 16.1% margin, and non-GAAP operating margin of 21.3%. GAAP diluted EPS was $1.72, with non-GAAP EPS at $2.49.
Align announced a restructuring plan including workforce reductions and manufacturing optimization, expecting $150-170 million in one-time charges in H2 2025. The company aims to achieve GAAP operating margins of 13-14% and non-GAAP margins above 22.5% in FY 2025.
Align Technology (NASDAQ:ALGN) has announced the commercial launch of its innovative Invisalign System with mandibular advancement featuring occlusal blocks in Malaysia. This breakthrough technology is designed to treat Class II skeletal malocclusion in growing patients aged 10-16 while simultaneously straightening their teeth.
The new system represents a significant advancement in treating Class II malocclusions, which affect 30-45% of cases globally. The technology features integrated solid occlusal blocks with laser welding for improved durability and engagement, enabling earlier mandibular advancement in cases with deep bite. Key benefits include efficient treatment through a single process, enhanced patient comfort with SmartTrack material, and predictable tooth movement using SmartForce features and SmartStage technology.
The product is currently available in select APAC markets with further expansion planned for 2025.Align Technology (NASDAQ:ALGN) has announced the commercial launch of its Invisalign Palatal Expander System in Malaysia, following its notification as a Class B medical device by the Malaysia Medical Device Authority. This innovative system, Align's first direct 3D printed orthodontic appliance, offers a metal-free alternative to traditional palatal expanders for skeletal and dental expansion.
The system consists of customized removable devices created using AI-driven orthodontic software and iTero intraoral digital scans. When combined with Invisalign First aligners, it provides a comprehensive early intervention treatment solution for growing patients. The technology is particularly significant for Phase 1 treatment, which represents 20% of orthodontic case starts annually and targets patients aged 6-10 years.
The expansion is now available across multiple Asia Pacific markets, including Australia, New Zealand, Hong Kong, Singapore, Vietnam, Japan, Thailand, India, and Malaysia.Align Technology (NASDAQ:ALGN) has announced the commercial launch of an innovative Invisalign System with mandibular advancement featuring occlusal blocks in Singapore. This breakthrough product is specifically designed for treating Class II skeletal and dental correction in growing patients aged 10-16 years.
The new system represents a significant advancement in orthodontic treatment, featuring integrated solid occlusal blocks that enable simultaneous mandibular advancement while aligning teeth. This innovation addresses Class II malocclusion, a common orthodontic problem affecting 30-45% of cases globally, where the lower jaw is positioned too far back relative to the upper jaw.
The product is currently available to Invisalign-trained doctors in Australia, New Zealand, Japan, Hong Kong, India, and Singapore, with planned expansion to additional APAC markets later in 2025.
Align Technology (NASDAQ:ALGN) has been announced as the title sponsor of Operation Smile's International Student Leadership Conference (ISLC) for the fifth consecutive year. The conference, in its 33rd year, will be held at the University of Maryland from July 21-27, 2025.
Align has committed over $1.6 million to student programs with Operation Smile, providing more than 130 scholarships since ISLC 2022. The scholarships cover travel costs and conference fees for students born with cleft conditions and those facing financial barriers across Operation Smile's network of 13,500 student volunteers from over 40 countries.
The partnership between Align Technology and Operation Smile spans more than a decade, supporting care for patients and working towards surgical excellence in 37 low- and middle-income countries.
Align Technology (NASDAQ: ALGN) has announced a strategic collaboration with Disney's upcoming movie sequel "Freakier Friday," set to release on August 8, 2025. The partnership features actress Julia Butters, a real-life Invisalign user, and includes product placement in the film alongside a comprehensive marketing campaign.
The multi-faceted collaboration encompasses co-branded content, social media campaigns, doctor's office activations, a Snapchat AR lens, and premiere events. The campaign aims to showcase how Invisalign clear aligners offer teens an effective and modern way to achieve confident smiles, while highlighting the system's near-invisibility and ease of use.
The marketing initiative leverages multiple channels including Disney+, Hulu, social media platforms, and orthodontist offices, reinforcing Align's commitment to teen confidence through smile transformation.
Align Technology (NASDAQ:ALGN) has announced the commercial availability of its innovative Invisalign System with mandibular advancement featuring occlusal blocks in India. This groundbreaking clear aligner product is specifically designed for Class II skeletal and dental correction in growing patients aged 10-16 years.
The system features integrated solid occlusal blocks that enable simultaneous mandibular advancement while aligning teeth, addressing approximately 30-45% of global malocclusions. Key benefits include efficient treatment through a single process, enhanced patient comfort with SmartTrack material, and predictable tooth movement using SmartForce features and SmartStage technology.
The product is currently available to Invisalign-trained doctors in Australia, New Zealand, Japan, Hong Kong, and India, with planned expansion to additional APAC markets later in 2025.
Align Technology (NASDAQ:ALGN) has announced the commercial launch of its Invisalign® Palatal Expander System in India following approval as a Class B medical device by the Central Drugs Standard Control Organization (CDSCO). This innovative system represents Align's first direct 3D printed orthodontic appliance.
The system offers a metal-free, removable alternative to traditional palatal expanders for treating skeletal and dental narrow maxilla. When combined with Invisalign First™ aligners, it provides doctors with a comprehensive early intervention treatment solution. The technology uses AI-driven orthodontic software and iTero™ intraoral digital scans to create customized devices that are changed daily, eliminating the need for manual screw adjustments.
This expansion into India follows successful launches in other Asia Pacific markets, including Australia, New Zealand, Hong Kong, Singapore, Vietnam, Japan, and Thailand, targeting the growing Phase 1 orthodontic treatment market, which represents 20% of orthodontic case starts annually.
Align Technology (NASDAQ: ALGN) has appointed Britt Vitalone, Executive Vice President and CFO of McKesson Corporation, to its Board of Directors and Audit Committee. Vitalone brings extensive healthcare industry financial expertise to Align's board, which has now expanded to 11 directors.
As McKesson's CFO, Vitalone oversees crucial functions including accounting, financial planning, treasury, investor relations, M&A, and tax. He also manages global procurement, corporate security, and McKesson Technology. Vitalone, who joined McKesson in 2006, will be included in Align's slate of director nominees for the 2026 Annual Meeting of Shareholders.